ATC Group: C08CA05 Nifedipine

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Cardiovascular system
2
Calcium channel blockers
3
Selective calcium channel blockers with mainly vascular effects
4
Dihydropyridine derivatives
5
C08CA05
Nifedipine

Active ingredients

Active Ingredient
Description

Nifedipine is a calcium antagonist of the 1,4-dihydropyridine type. Calcium antagonists reduce the transmembranal influx of calcium ions through the slow calcium channel into the cell. As a specific and potent calcium antagonist, nifedipine acts particularly on the cells of the myocardium and the smooth muscle cells of the coronary arteries and the peripheral resistance vessels. The main action of nifedipine is to relax arterial smooth muscle, both in the coronary and peripheral circulation. Nifedipine Tablets are formulated to achieve controlled delivery of nifedipine in a release profile sufficient to enable once-daily administration to be effective in clinical use.

Medicines in this ATC group

Drug
Countries

Austria Brazil Canada Hong Kong Ireland ...

France Tunisia

United Kingdom

Australia

Australia New Zealand

United Kingdom

Hong Kong

South Africa

Austria

Singapore

South Africa

South Africa

South Africa

United Kingdom

Hong Kong Lithuania Singapore

Lithuania

South Africa

Singapore

United Kingdom

South Africa

Cyprus Hong Kong

United Kingdom

South Africa

Cyprus South Africa

United Kingdom

United Kingdom

South Africa

Cyprus Hong Kong Singapore

Brazil

New Zealand

United States

United Kingdom

United Kingdom

Hong Kong

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
CY
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
CY
Structured Product Labeling (SPL)
US
Structured Product Labeling (SPL)
US